|
| 36527600 | Pharmacokinetics and Pharmacodynamics of Bimagrumab (BYM338). | | 2023 |
| 36446256 | Unsupervised machine-learning algorithms for the identification of clinical phenotypes in the osteoarthritis initiative database. | Seminars in Arthritis and Rheumatism | 2023 |
| 37988976 | Efficacy and safety of iscalimab, a novel anti-CD40 monoclonal antibody, in moderate-to-severe myasthenia gravis: A phase 2 randomized study. | | 2023 |
| 37722125 | Lessons Learned While Grieving. | | 2023 |
| 35066104 | Reproducibility, relevance and reliability as barriers to efficient and credible biomedical technology translation. | Advanced Drug Delivery Reviews | 2022 |
| 36038279 | Longitudinal Changes in MRI Muscle Morphometry and Composition in People With Inclusion Body Myositis. | Neurology | 2022 |
| 35545258 | Multicomponent intervention to prevent mobility disability in frail older adults: randomised controlled trial (SPRINTT project). | BMJ | 2022 |
| 36456835 | Angiopoietin-like 3-derivative LNA043 for cartilage regeneration in osteoarthritis: a randomized phase 1 trial. | Nature Medicine | 2022 |
| 33439265 | Effect of Bimagrumab vs Placebo on Body Fat Mass Among Adults With Type 2 Diabetes and Obesity: A Phase 2 Randomized Clinical Trial. | JAMA network open | 2021 |
| 33264516 | Safety and pharmacokinetics of bimagrumab in healthy older and obese adults with body composition changes in the older cohort. | Journal of Cachexia, Sarcopenia and Muscle | 2020 |
| 33442578 | A Roadmap to Inform Development, Validation and Approval of Digital Mobility Outcomes: The Mobilise-D Approach. | Digital Biomarkers | 2020 |
| 32744862 | Effects of Interleukin-1β Inhibition on Incident Hip and Knee Replacement : Exploratory Analyses From a Randomized, Double-Blind, Placebo-Controlled Trial. | Annals of Internal Medicine | 2020 |
| 33074327 | Bimagrumab vs Optimized Standard of Care for Treatment of Sarcopenia in Community-Dwelling Older Adults: A Randomized Clinical Trial. | JAMA network open | 2020 |
| 30894455 | Colony-Stimulating Factor-1 Antibody Lacnotuzumab in a Phase 1 Healthy Volunteer Study and Mechanistic Investigation of Safety Outcomes. | J Pharmacol Exp Ther | 2019 |
| 31774406 | Continuous Digital Monitoring of Walking Speed in Frail Elderly Patients: Noninterventional Validation Study and Longitudinal Clinical Trial. | JMIR mHealth and uHealth | 2019 |
| 30387136 | Emerging Interventions for Elderly Patients-The Promise of Regenerative Medicine. | Clinical Pharmacology and Therapeutics | 2019 |
| 30009955 | How soon will digital endpoints become a cornerstone for future drug development? | Drug Discovery Today | 2019 |
| 30095981 | Activin Type II Receptor Blockade for Treatment of Muscle Depletion in Chronic Obstructive Pulmonary Disease. A Randomized Trial. | American Journal of Respiratory and Critical Care Medicine | 2019 |
| 31237312 | Development of Pharmacotherapies for the Treatment of Sarcopenia. | Journal of frailty & aging,The | 2019 |
| 29148045 | Reply to: New Hope for Sarcopenia. | | 2018 |
| 28643356 | Bimagrumab improves body composition and insulin sensitivity in insulin-resistant individuals. | Diabetes, Obesity and Metabolism | 2018 |
| 30261246 | The "Sarcopenia and Physical fRailty IN older people: multi-componenT Treatment strategies" (SPRINTT) randomized controlled trial: Case finding, screening and characteristics of eligible participants. | Exp Gerontol | 2018 |
| 30337273 | Safety, tolerability, and preliminary efficacy of an IGF-1 mimetic in patients with spinal and bulbar muscular atrophy: a randomised, placebo-controlled trial. | Lancet Neurology, The | 2018 |
| 29566437 | Effects of bimagrumab, an activin receptor type II inhibitor, on pituitary neurohormonal axes. | Clinical Endocrinology | 2018 |
| 29214748 | Alterations in the in vitro and in vivo regulation of muscle regeneration in healthy ageing and the influence of sarcopenia. | Journal of Cachexia, Sarcopenia and Muscle | 2018 |
| 29412436 | Implications of ICD-10 for Sarcopenia Clinical Practice and Clinical Trials: Report by the International Conference on Frailty and Sarcopenia Research Task Force. | J Frailty Aging | 2018 |
| 28144913 | The "Sarcopenia and Physical fRailty IN older people: multi-componenT Treatment strategies" (SPRINTT) project: advancing the care of physically frail and sarcopenic older people. | Aging clinical and experimental research | 2017 |
| 28596451 | Serum Insulin-Like Growth Factor 1 and the Risk of Ischemic Stroke: The Framingham Study. | Stroke | 2017 |
| 28653345 | Treatment of Sarcopenia with Bimagrumab: Results from a Phase II, Randomized, Controlled, Proof-of-Concept Study. | | 2017 |
| 28436937 | Efficacy of anti-sclerostin monoclonal antibody BPS804 in adult patients with hypophosphatasia. | Journal of Clinical Investigation | 2017 |
| 28188558 | Rationale for a preliminary operational definition of physical frailty and sarcopenia in the SPRINTT trial. | Aging Clin Exp Res | 2017 |
| 28155179 | The need of operational paradigms for frailty in older persons: the SPRINTT project. | Aging clinical and experimental research | 2017 |
| 28160253 | Physical frailty and sarcopenia (PF&S): a point of view from the industry. | Aging clinical and experimental research | 2017 |
| 28144914 | The "Sarcopenia and Physical fRailty IN older people: multi-componenT Treatment strategies" (SPRINTT) randomized controlled trial: design and methods. | Aging Clin Exp Res | 2017 |
| 27883164 | Sarcopenia Trials in Specific Diseases: Report by the International Conference on Frailty and Sarcopenia Research Task Force. | J Frailty Aging | 2016 |
| 27454226 | Loss of oxidative defense and potential blockade of satellite cell maturation in the skeletal muscle of patients with cancer but not in the healthy elderly. | Aging | 2016 |
| 26366378 | PHARMACOLOGICAL INTERVENTIONS IN FRAILTY AND SARCOPENIA: REPORT BY THE INTERNATIONAL CONFERENCE ON FRAILTY AND SARCOPENIA RESEARCH TASK FORCE. | J Frailty Aging | 2015 |
| 25363509 | Prospect for pharmacological therapies to treat skeletal muscle dysfunction. | Calcified Tissue International | 2015 |
| 26337973 | Serum Leptin Levels and the Risk of Stroke: The Framingham Study. | Stroke | 2015 |
| 24706014 | Insulin-like growth factor-1 and risk of Alzheimer dementia and brain atrophy. | Neurology | 2014 |
| 25317071 | Influence of exercise on the metabolic profile caused by 28 days of bed rest with energy deficit and amino acid supplementation in healthy men. | International Journal of Medical Sciences | 2014 |
| 25381300 | Treatment of sporadic inclusion body myositis with bimagrumab. | Neurology | 2014 |
| 24404136 | Clinical classification of cancer cachexia: phenotypic correlates in human skeletal muscle. | PLoS ONE | 2014 |
| 24325895 | The "cytokine for gerontologists" has some company. | | 2014 |
| 23784898 | Cardiometabolic risks during anabolic hormone supplementation in older men. | Obesity (Silver Spring) | 2013 |
| 21748366 | Value of measuring muscle performance to assess changes in lean mass with testosterone and growth hormone supplementation. | Eur J Appl Physiol | 2012 |
| 22392875 | Plasma phosphatidylcholine concentrations of polyunsaturated fatty acids are differentially associated with hip bone mineral density and hip fracture in older adults: the Framingham Osteoporosis Study. | J Bone Miner Res | 2012 |
| 22623384 | Plasma pyridoxal-5-phosphate is inversely associated with systemic markers of inflammation in a population of U.S. adults. | Journal of Nutrition | 2012 |
| 22865205 | Biomarkers of sarcopenia in clinical trials-recommendations from the International Working Group on Sarcopenia. | J Cachexia Sarcopenia Muscle | 2012 |
| 22561528 | Prospects for the development of effective pharmacotherapy targeted at the skeletal muscles in chronic obstructive pulmonary disease: a translational review. | Thorax | 2012 |